Continued research led to the first GLP-1 drugs approved for weight loss in people with obesity or overweight: liraglutide or Saxenda in 2014, semaglutide as Wagovy in 2021 and tirzepatide as Zepbound in 2023
Understanding your genetic predispositions in peptide pathways empowers you and your provider to make more informed choices about formulation selection, dose titration strategy, and realistic expectations for weight loss and metabolic improvement
5 Other Surprising Health Benefits of Okra With such significant potential benefits to major human health problems, it is surprising that research has uncovered even more possible benefits of okra including to skin and energy levels
Mild, temporary sensitivity may occur but is rare
These findings suggest that GPX4 inhibition may induce ferroptosis in oligodendrocytes, with Lip-1 serving as a potent ferroptosis antagonist
The dose figures above are the documented per-dose amounts
